The evidence base for breast cancer screening

Preventive Medicine

Volumn 53, Issue 3, 2011, Pages 100-102

  Glasziou, Paul ^a   Houssami, Nehmat ^b  

^a BOND UNIVERSITY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Breast neoplasms diagnosis; Breast neoplasms radiography; Mammography statistics and numerical data

Indexed keywords

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; CONTROLLED STUDY; EVIDENCE BASED MEDICINE; FALSE POSITIVE RESULT; FEMALE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; OVERDIAGNOSIS; PRIORITY JOURNAL; RISK REDUCTION; SYSTEMIC THERAPY; ATTITUDE TO HEALTH; BREAST TUMOR; EARLY DIAGNOSIS; METHODOLOGY; PREVENTIVE MEDICINE; WOMEN'S HEALTH;

BREAST NEOPLASMS; EARLY DETECTION OF CANCER; EVIDENCE-BASED MEDICINE; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; PREVENTIVE MEDICINE; RISK REDUCTION BEHAVIOR; WOMEN'S HEALTH;

EID: 80051556282     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2011.05.011     Document Type: Article

References (24)

1. Berry D.A., Kronin K.A., Plevritis S.K., et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N. Engl. J. Med. 2005, 353:1784-1792.
2. Biesheuvel C., Barratt A., Howard K., Houssami N., Irwig L. Effects of study methods and biases on estimates of invasive breast cancer overdetection with mammography screening: a systematic review. Lancet Oncol. 2007, 8:1129-1138.
3. Fletcher S.W. Whither scientific deliberation in health policy recommendations? Alice in the Wonderland of breast-cancer screening. N. Engl. J. Med. 1997, 336(16):1180-1183. (Apr 17).
4. Gabe R., Duffy S.W. Evaluation of service screening mammography in practice: the impact on breast cancer mortality. Ann. Oncol. 2005, 16(Supplement 2):ii153-ii162.
5. Glasziou P.P. Meta-analysis adjusting for compliance: the example of screening for breast cancer. J. Clin. Epidemiol. 1992, 45(11):1251-1256. (Nov).
6. Glasziou P., Irwig L. The quality and interpretation of mammographic screening trials for women ages 40-49. J. Natl. Cancer Inst. Monogr. 1997, 22:73-77.
7. Glasziou P.P., Woodward A.J., Mahon C.M. Mammographic screening trials for women aged under 50. A quality assessment and meta-analysis. Med. J. Aust. 1995, 162(12):625-629. (Jun 19).
8. Gøtzsche P.C., Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst. Rev. 2009, 7(4):CD001877. (Oct).
9. Hofvind S., Thoresen S., Tretli S. The cumulative risk of a false-positive recall in the Norwegian Breast Cancer Screening Program. Cancer 2004, 101:1501-1507.
10. Hubbard R.A., Miglioretti D.L., Smith R.A. Modelling the cumulative risk of a false-positive screening test. Stat. Methods Med. Res. 2010, 19:429-449.
11. Jørgensen K.J., Gøtzsche P.C. Content of invitations for publicly funded screening mammography. BMJ 2006, 332(7540):538-541. (Mar 4).
12. Kalager M., Zelen M., Langmark F., Adami H.O. Effect of screening mammography on breast-cancer mortality in Norway. N. Engl. J. Med. 2010, 363:1203-1210.
13. Mandelblatt J.S., Cronin K.A., Bailey S., et al. Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann. Intern. Med. 2009, 151(10):738-747.
14. Mathieu E., Barratt A.L., Davey H.M., McGeechan K., Howard K., Houssami N. Informed choice in mammography screening: a randomized trial of a decision aid for 70year old women. Arch. Intern. Med. 2007, 167(19):2039-2046.
15. Mathieu E., Barratt A.L., McGeechan K., Davey H.M., Howard K., Houssami N. Helping women make choices about mammography screening: an online randomised trial of a decision aid for 40year old women. Patient Educ. Couns. 2010, 81(1):63-72.
16. Moss S.M., Cuckle H., Evans A., Johns L., Waller M. Effect of mammographic screening from age 40years on breast cancer mortality at 10years' follow-up: a randomised controlled trial. Lancet 2006, 368(9552):2053-2060. Trial Management Group, (Dec 9).
17. National Institutes of Health Consensus Developmental Panel National Institutes of Health Consensus Development Conference Statement: breast cancer screening for women ages 40-49, January 21-23, 1997. J. Natl. Cancer Inst. Monogr. 1997, (22):vii-xviii.
18. Nelson H.D., Tyne K., Naik A., et al. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann. Intern. Med. 2009, 151(10):727-737.
19. Njor S.H., Olsen A.H., Schwartz W., Vejborg I., Lynge E. Predicting the risk of a false-positive test for women following a mammography screening programme. J. Med. Screen. 2007, 14:94-97.
20. Paul C., Nicholls R., Priest P., McGee R. Making policy decisions about population screening for breast cancer: the role of citizens' deliberation. Health Policy 2008, 85(3):314-320. (Mar, Epub 2007 Oct 10).
21. Schopper D., de Wolf C. How effective are breast cancer screening programmes by mammography? Review of the current evidence. EJC 2009, 45:1916-1923.
22. Tabar L., Duffy S.W., Yen M.-F., et al. All-cause mortality among breast cancer patients in a screening trial: support for breast cancer mortality as an end point. J. Med. Screen. 2002, 9:159-162.
23. US Preventive Services Task Force Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann. Intern. Med. 2009, 151(10):716-726. (Nov 17, W-236).
24. van Ravesteyn N.T., Heijnsdijk E.A.M., de Koning H.J. More on screening mammography. N. Engl. J. Med. 2011, 3634(3):281-285.